|

A Pilot Prospective Clinical Trial Using Remote Monitoring for Cancer Patients Undergoing Outpatient Chemotherapy

RECRUITINGSponsored by Inova Health Care Services
Actively Recruiting
SponsorInova Health Care Services
Started2023-10-26
Est. completion2025-11-01
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →

NCT06106360

Summary

A pilot study using remote monitoring technology developed by Locus Health in cancer patients undergoing chemotherapy treatment.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Planned to be treated with a new cytotoxic chemotherapy or chemoimmunotherapy regimen for a solid tumor or malignant hematology condition for at least 4 months
* ECOG performance status of 0-2
* Age of 18 or older patient with any solid tumor or hematologic malignancy
* English or Spanish speaker
* Own an Apple iPhone
* Capacity and willingness to provide informed consent

Exclusion Criteria:

* Patients undergoing concurrent radiation since they will be seen on a daily basis by clinic care teams and are not likely to benefit from active remote patient monitoring
* Patients unwilling or unable to comply with the protocol, including wearing the Apple Watch (including recharging daily) and answering queries on the Locus Health iPhone application per the protocol and study group cadence
* Any condition for which in the Investigator's opinion would limit compliance with study requirements

Conditions3

CancerHematological MalignancySolid Tumor

Locations1 site

Inova Schar Cancer Institute
Fairfax, Virginia, 22031
Elahe Mollapour571-472-4724elahe.mollapour@inova.org

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.